Acute Kidney Injury Clinical Trial
Official title:
Retrospective Analysis of Aminoglycoside-associated Acute Renal Injury in Septic Critically Ill Patients
The purpose of the present study is to determine whether administration of aminoglycosides in septic critically ill patient is a risk factor for acute kidney injury
Severe sepsis and septic shock despite recent advances in surviving sepsis campaign remain
encumbered by a high mortality rate close to 30%. One cornerstone of the management of these
patients remains the early and appropriate antibiotic administration, , which must be also
active at the site of infection. Aminoglycosides are often administered in combination with
beta lactams in this context . According to the progress in pharmacokinetic management
achieved over the past decade, their safety and efficiency tended to increase but many
uncertainties remain. The purpose of the present study is to determine whether
administration of aminoglycosides in septic critically ill patient is a risk factor for
acute kidney injury.
Study design: This is an open retrospective monocentric cohort study including septic
critically ill patients from november 2008 to january 2010. To determine the incidence and
the specific risk of nephrotoxicity of aminoglycosides, only hospitalized patients without
initial acute kidney injury or with rapidly improving kidney function during the three first
days will be included.Primary outcome will be the occurrence of acute kidney injury assessed
with the RIFLE classification (Risk, Injury, Failure, Loss, and End-stage kidney disease)
from day 4 to day 15. Patients receiving aminoglycosides will be compared with a control
group, i.e. not receiving them. We estimated hazard ratios (HR) and 95% confidence intervals
(CI) with adjusted and propensity score (PS)-matched Cox-proportional hazards models.
;
Observational Model: Cohort, Time Perspective: Retrospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05538351 -
A Study to Support the Development of the Enhanced Fluid Assessment Tool for Patients With Acute Kidney Injury
|
||
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Completed |
NCT03938038 -
Guidance of Ultrasound in Intensive Care to Direct Euvolemia
|
N/A | |
Recruiting |
NCT05805709 -
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
|
N/A | |
Recruiting |
NCT05318196 -
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
|
||
Recruiting |
NCT05897840 -
Continuous Central Venous Oxygen Saturation Measurement as a Tool to Predict Hemodynamic Instability Related to Renal Replacement Therapy in Critically Ill Patients
|
N/A | |
Recruiting |
NCT04986137 -
Fractional Excretion of Urea for the Differential Diagnosis of Acute Kidney Injury in Cirrhosis
|
||
Terminated |
NCT04293744 -
Acute Kidney Injury After Cardiac Surgery
|
N/A | |
Completed |
NCT04095143 -
Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury
|
||
Not yet recruiting |
NCT06026592 -
Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients
|
||
Not yet recruiting |
NCT06064305 -
Transcriptional and Proteomic Analysis of Acute Kidney Injury
|
||
Terminated |
NCT03438877 -
Intensive Versus Regular Dosage For PD In AKI.
|
N/A | |
Terminated |
NCT03305549 -
Recovery After Dialysis-Requiring Acute Kidney Injury
|
N/A | |
Completed |
NCT05990660 -
Renal Assist Device (RAD) for Patients With Renal Insufficiency Undergoing Cardiac Surgery
|
N/A | |
Completed |
NCT04062994 -
A Clinical Decision Support Trial to Reduce Intraoperative Hypotension
|
||
Terminated |
NCT02860130 -
Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)
|
Phase 3 | |
Completed |
NCT06000098 -
Consol Time and Acute Kidney Injury in Robotic-assisted Prostatectomy
|
||
Not yet recruiting |
NCT05548725 -
Relation Between Acute Kidney Injury and Mineral Bone Disease
|
||
Completed |
NCT02665377 -
Prevention of Akute Kidney Injury, Hearttransplant, ANP
|
Phase 3 | |
Terminated |
NCT03539861 -
Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients
|
N/A |